NewCardio Revenue from 2010 to 2026
| NWCI Stock | USD 0.0001 0.00 0.00% |
Projected quarterly revenue analysis
Projected quarterly revenue analysis of NewCardio provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of NewCardio match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in NewCardio's stock price.
Check NewCardio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NewCardio's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 5.6 M, as well as many indicators such as Price To Sales Ratio of 89.26, Dividend Yield of 0.0 or Days Sales Outstanding of 40.43. NewCardio financial statements analysis is a perfect complement when working with NewCardio Valuation or Volatility modules.
NewCardio | Revenue | Build AI portfolio with NewCardio Stock |
The Revenue trend for NewCardio offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether NewCardio is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest NewCardio's Revenue Growth Pattern
Below is the plot of the Total Revenue of NewCardio over the last few years. Total revenue comprises all receipts NewCardio generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. NewCardio's Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NewCardio's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 257.4 K | 10 Years Trend |
|
Total Revenue |
| Timeline |
NewCardio Revenue Regression Statistics
| Arithmetic Mean | 247,671 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 26.51 | |
| Mean Deviation | 29,138 | |
| Median | 257,399 | |
| Standard Deviation | 65,664 | |
| Sample Variance | 4.3B | |
| Range | 310.8K | |
| R-Value | 0.52 | |
| Mean Square Error | 3.4B | |
| R-Squared | 0.27 | |
| Significance | 0.03 | |
| Slope | 6,757 | |
| Total Sum of Squares | 69B |
NewCardio Revenue History
Other Fundumenentals of NewCardio
| Cost Of Revenue | ||
| Stock Based Compensation To Revenue | ||
| Sales General And Administrative To Revenue | ||
| Research And Ddevelopement To Revenue |
NewCardio Revenue component correlations
Click cells to compare fundamentals
About NewCardio Financial Statements
Investors use fundamental indicators, such as NewCardio's Revenue, to determine how well the company is positioned to perform in the future. Although NewCardio's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 296 K | 310.8 K | |
| Cost Of Revenue | 175.1 K | 183.9 K | |
| Research And Ddevelopement To Revenue | 12.54 | 11.14 | |
| Capex To Revenue | 0.32 | 0.34 | |
| Revenue Per Share | 0.01 | 0.01 | |
| Ebit Per Revenue | (42.26) | (40.15) |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of NewCardio Correlation against competitors. For more detail on how to invest in NewCardio Stock please use our How to Invest in NewCardio guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is there potential for Health Care Technology market expansion? Will NewCardio introduce new products? Factors like these will boost the valuation of NewCardio. Anticipated expansion of NewCardio directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about NewCardio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding NewCardio requires distinguishing between market price and book value, where the latter reflects NewCardio's accounting equity. The concept of intrinsic value - what NewCardio's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push NewCardio's price substantially above or below its fundamental value.
It's important to distinguish between NewCardio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NewCardio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, NewCardio's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.